Stockscreener 앱 받기
0.85
8.83%
0.069
시간 외 거래:
2.59
1.74
+204.71%
전일 마감가:
$0.781
열려 있는:
$0.805
하루 거래량:
253.90K
Relative Volume:
2.52
시가총액:
$30.76M
수익:
$4.14M
순이익/손실:
$-5.58M
주가수익비율:
-4.4737
EPS:
-0.19
순현금흐름:
$-2.98M
1주 성능:
+13.59%
1개월 성능:
-13.27%
6개월 성능:
-42.18%
1년 성능:
-37.96%
1일 변동 폭
$0.80
$0.8896
1주일 범위
$0.7512
$0.8896
52주 변동 폭
$0.711
$2.20
Dyadic International Inc De Stock (DYAI) Company Profile
명칭
Dyadic International Inc De
전화
561-743-8333
주소
1044 NORTH U.S. HIGHWAY ONE, JUPITER
DYAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.53 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1668 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
Dyadic International Inc De 주식(DYAI)의 최신 뉴스
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewswire
Dyadic Applied BioSolutions: Strategic Shift and Financial Growth - TipRanks
Dyadic's Strategic Milestone and Capital Raise: A Catalyst for 2026 Commercialization - AInvest
Earnings call transcript: Dyadic Q2 2025 sees revenue growth, stock dips - Investing.com Nigeria
Earnings call transcript: Dyadic Q2 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa
DYADIC INTERNATIONAL Earnings Results: $DYAI Reports Quarterly Earnings - Quiver Quantitative
Dyadic Transforms from R&D to Commercial Player with Revenue Surge, Multiple Product Launches Coming - Stock Titan
Global Protein Hydrolysis Enzymes Industry Study: Market Analysis 2025-2035 - MarketReports.us
Will earnings trigger a reversal in Dyadic International Inc.2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
Using fundamentals and technicals on KPRXAlgorithmic Prediction of Market Breakouts - Newser
Dyadic International (DYAI) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Should you hold or exit Kilroy Realty Corporation nowShort Term Momentum Based Trading Strategy - Newser
Specialty Enzymes Market to Reach $9.2 Billion by 2029, Driven by Biotech Innovation and Public Funding - GlobeNewswire
Is it time to cut losses on Camtek Ltd.Free Trade Scanner With Buy Zone Alerts - Newser
Dyadic International, Inc. to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13 - Quiver Quantitative
Dyadic International Earnings: Precision Protein Biotech Leader Reports Q2 Results August 13 - Stock Titan
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 - GlobeNewswire
Dyadic International Closes $5.3 Million Stock Offering - The Globe and Mail
Is Dyadic International Inc. building a consolidation baseFree Trade Timing Strategy With Technical Data - Newser
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewswire
Dyadic International prices $5.75 million public offering By Investing.com - Investing.com UK
Dyadic International, Inc. Announces Pricing of $5.75 Million Public Offering of Common Stock - Quiver Quantitative
Economic Sector Performance Dashboards - Yahoo Finance
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewswire
Dyadic International prices public offering of 6 million shares - Investing.com Australia
Dyadic International prices public offering of 6 million shares By Investing.com - Investing.com Canada
Dyadic International Raises Capital: 6 Million Share Offering to Fuel Precision Protein Development - Stock Titan
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
Dyadic International launches public stock offering; shares down 11.5% - MSN
Dyadic International launches public offering of common stock - Investing.com Australia
Dyadic International Announces Strategic Stock Offering: Biotech Platform Expansion Plans Revealed - Stock Titan
What high frequency data says about PRPLDaily Trade Monitor with Pattern Alerts - Newser
How volatile is Dyadic International Inc. stock compared to the marketAchieve rapid portfolio growth with expert guidance - Jammu Links News
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic International Receives Nasdaq Deficiency Notice - TipRanks
Dyadic International Shifts Focus to Commercial Enterprise - TipRanks
DYAI 8-K: Dyadic Shifts to Commercial Focus With C1 & Dapibus™ Platforms | AIRE SEC FilingForm 8-K - Stock Titan
Dyadic International Receives Nasdaq Deficiency Notice: Compliance Deadline and Potential Delisting - AInvest
Candel Therapeutics Inc. Stock Analysis and ForecastSkyrocketing returns - Jammu Links News
What analysts say about The Real Brokerage Inc. stockOutstanding capital returns - jammulinksnews.com
P 500Short Term Profit Focus - Newser
Why EFC.PRD stock attracts strong analyst attentionStrategic High Profit Opportunities - Newser
Dyadic rebrands as Applied BioSolutions to focus on commercial growth By Investing.com - Investing.com Canada
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions - Yahoo Finance
Dyadic International shareholders approve board proposals at annual meeting - Investing.com
Millennium Management LLC Takes Position in Dyadic International, Inc. (NASDAQ:DYAI) - Defense World
Kopin Co. (NASDAQ:KOPN) Shares Acquired by Bank of America Corp DE - Defense World
Bank of America Corp DE Grows Stock Position in Potbelly Co. (NASDAQ:PBPB) - Defense World
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Jane Street Group LLC Has $51,000 Position in Altus Power, Inc. (NYSE:AMPS) - Defense World
Comprehensive Report Reviews the Biotechnology Research Investment Driving Specialty Enzymes Market Growth:... - WhaTech
Dyadic International Inc De (DYAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
1.72%
자본화:
|
볼륨(24시간):